Factbox: More Roundup trials, appeals in store for Bayer after $2 billion verdict

Bayer shares continued to fall on Tuesday after a California jury on Monday awarded more than $2 billion in damages to a couple who alleged that the company's glyphosate-based weed killer Roundup caused their cancers.